Evidence map›Paper›PMID 35200651›Full record

ReviewMarine drugs2022

Lipophilic Toxins in Chile: History, Producers and Impacts.

Patricio A Díaz, Gonzalo Álvarez, Gemita Pizarro, Juan Blanco, Beatriz Reguera

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 42 citations in OpenAlex.

  1. Characteristics of aMarine drugs · 2026
    Article
  2. Unveiling the 2017Microorganisms · 2025
    Article
  3. Overview of Patagonian Red Octopus (Animals : an open access journal from MDPI · 2025
    Review
  4. Article
  5. Article
  6. Identification of aMarine drugs · 2023
    Article
  7. Review
  8. Marine drugs · 2023
    Article
  9. Article
  10. Journal of plankton research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Patricio A DíazCentro i~mar (CeBiB), Universidad de Los Lagos, Casilla 557, Puerto Montt 5480000, Chile.ORCID 0000-0002-9403-8151
Gonzalo ÁlvarezDepartamento de Acuicultura, Facultad de Ciencias del Mar, Universidad Católica del Norte, Larrondo 1281, Coquimbo 1781421, Chile.ORCID 0000-0001-5812-1559
Gemita PizarroCentro de Estudios de Algas Nocivas (CREAN), Instituto de Fomento Pesquero (IFOP), Enrique Abello 0552, Punta Arenas 6200000, Chile.
Juan BlancoCentro de Investigacións Mariñas (Xunta de Galicia), Apto. 13, 36620 Vilanova de Arousa, Pontevedra, Spain.ORCID 0000-0003-2123-7747
Beatriz RegueraCentro Oceanográfico de Vigo (IEO, CSIC), Subida a Radio Faro 50, 36390 Vigo, Pontevedra, Spain.ORCID 0000-0003-4582-9798
Centro Oceanográfico de VigoInstituto de Fomento Pesquero · CLUniversidad Católica del Norte · CLUniversidad de Los Lagos · CLXunta de Galicia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A variety of microalgal species produce lipophilic toxins (LT) that are accumulated by filter-feeding bivalves. Their negative impacts on human health and shellfish exploitation are determined by toxic potential of the local strains and toxin biotransformations by exploited bivalve species. Chile has become, in a decade, the world's major exporter of mussels (

Indexed as

AnimalsBiological AssayBivalviaChileHumansMarine ToxinsMiceMicroalgaeShellfish PoisoningMarine ToxinsChilediarrhetic shellfish poisoningDinophysis acuminataDinophysis acutaHAB monitoringharmful algal bloomslipophilic toxins

Identifiers

PMID35200651
PMCPMC8874607
OpenAlexW4210506020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.